USFDA successfully concludes inspection at Unichem Labs Ghaziabad facility
Written By : Ruchika Sharma
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2024-02-14 06:45 GMT | Update On 2024-03-21 15:22 GMT
Advertisement
Mumbai: Unichem Labs has announced that the United States Food and Drug Administration (USFDA) has successfully concluded inspection without any observation at the Company's Ghaziabad (Uttar Pradesh) formulation facility.
The inspection was held from February 7, 2024 to February 13, 2024.
"The United States Food and Drug Administration (USFDA) conducted inspection at the Company’s Ghaziabad (Uttar Pradesh) formulation facility from February 7, 2024 to February 13, 2024. The inspection was successfully concluded without any observation," Unichem Labs stated in a BSE filing.
"The Company takes the quality and compliance issues with utmost importance and remains committed to maintain the same across all its manufacturing facilities," it further added.
Headquartered in Mumbai, Unichem Laboratories Limited is an international, integrated, specialty pharmaceutical company. The company was founded in 1944 by Padmabhushan Late Mr. Amrut V Mody. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in several markets across the world.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.